Rituximab 100mg, 500mg Injection
Rituximab 100mg, 500mg Injection is an Anticancer drug. It is a genetically engineered chimeric human monoclonal antibody. This injection is a colorless, sterile, clear solution that is packed in a single-use vial. Internationally it is known by the name of Rituxan and Mabthera. And in Indian pharmacies, it is available under the brand name Ristova.
Rituximab 100mg, 500mg Injection is used for treating patients suffering with:
Rituxan injection targets the CD20 antigen available on the surface of mature-B and pre-B lymphocytes. This medication binds with CD20 and mediates B-cell lysis.
Some drugs that might react with Rituximab 100mg, 500mg Injection are Tofacitinib, Fingolimod, and Natalizumab.
1. What is Ristova Injection?
Ristova is an anti-cancer medicine containing rituximab, a monoclonal antibody that targets the CD20 antigen on B lymphocytes. Lotus International lists Ristova in 100 mg and 500 mg injection presentations.
2. What is Ristova (Rituximab) used for?
Rituximab is used in the treatment of certain non-Hodgkin lymphomas and chronic lymphocytic leukaemia (CLL). Depending on the approved indication and treatment protocol, it is also used for certain autoimmune conditions, including rheumatoid arthritis and granulomatosis with polyangiitis.
3. How does Ristova (Rituximab) work?
Rituximab binds to the CD20 antigen found on B cells. This promotes depletion of targeted B lymphocytes, helping reduce abnormal B-cell activity in diseases for which rituximab is indicated.
4. What strengths of Ristova are available?
Ristova is available as 100 mg/10 mL and 500 mg/50 mL single-dose vials. It is supplied as a concentrate for intravenous infusion and should be prepared and administered by qualified healthcare professionals.
5. Can international buyers source Ristova from Lotus International?
Yes. Pharmaceutical importers, distributors, wholesalers, hospitals and procurement organizations can contact Lotus International regarding Ristova supply, bulk quantities, product availability, packaging and export documentation. Destination-market regulatory and cold-chain requirements should be confirmed before procurement.